BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24426726)

  • 1. Carcinosarcoma of the uterus-a single institution retrospective analysis of the management and outcome and a brief review of literature.
    Anupama R; Kuriakose S; Vijaykumar DK; Pavithran K; Jojo A; Indu RN; Sheejamol VS
    Indian J Surg Oncol; 2013 Sep; 4(3):222-8. PubMed ID: 24426726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management.
    Kanthan R; Senger JL
    Obstet Gynecol Int; 2011; 2011():470795. PubMed ID: 22007228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
    Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma.
    Yoon G; Kim YS; Kim BG; Bae DS; Lee JW
    J Gynecol Oncol; 2011 Dec; 22(4):292-4. PubMed ID: 22247807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
    Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
    Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of early uterine sarcomas: disentangling adjuvant modalities.
    Zagouri F; Dimopoulos AM; Fotiou S; Kouloulias V; Papadimitriou CA
    World J Surg Oncol; 2009 Apr; 7():38. PubMed ID: 19356236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Grade Endometrial Cancer-Behaviour and Outcomes at a Tertiary Cancer Centre.
    Lakhwani P; Agarwal P; Goel A; Nayar N; Pande P; Kumar K
    Indian J Surg Oncol; 2019 Dec; 10(4):662-667. PubMed ID: 31866730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Ann Surg Oncol; 2010 Mar; 17(3):861-8. PubMed ID: 19921530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases.
    Grasso S; Loizzi V; Minicucci V; Resta L; Camporeale AL; Cicinelli E; Cormio G
    Oncology; 2017; 92(4):197-204. PubMed ID: 28092915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous type of malignant mixed Mullerian tumor of the uterus presenting as a cervical mass.
    Kuyumcuoğlu U; Kale A
    J Chin Med Assoc; 2009 Oct; 72(10):533-5. PubMed ID: 19837648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.